{"id":825369,"date":"2025-03-13T08:10:10","date_gmt":"2025-03-13T12:10:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/"},"modified":"2025-03-13T08:10:10","modified_gmt":"2025-03-13T12:10:10","slug":"shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/","title":{"rendered":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options"},"content":{"rendered":"<div class=\"mw_release\">\n<p>PHILADELPHIA, March  13, 2025  (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating the fairness of the recently announced buyout of Checkpoint Therapeutics, Inc. (\u201cCheckpoint\u201d) (NASDAQ: CKPT) shareholders.<\/p>\n<p>\n        <strong><br \/>\n          <em>Click here for additional information: <\/em><br \/>\n        <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QVnJtehga4Iu1dbVzC3dOurqz4jkW4n4gyD8cXLaM_641VQCk_Zge7mCapi0NXxQQ7N-auENd6XrlPF3EdYKvEQ3X2V_ldMh0B8rxeaHvBrdo2I_SURa7domuVwlCsI0uMJM6gZ7xIExyokmm4uthQ==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <em>https:\/\/kaskelalaw.com\/case\/checkpoint\/<\/em><br \/>\n          <\/strong><br \/>\n        <\/a>\n      <\/p>\n<p>On March 9, 2025, Checkpoint announced that it had agreed to be acquired by Sun Pharmaceutical Industries Ltd. at an upfront price of <strong><em>$4.10 per share<\/em><\/strong> in cash plus a non-transferable contingent value right (CVR) worth up to an additional $0.70 in cash upon the achievement of certain milestones. Following the closing of the proposed transaction, Checkpoint\u2019s shareholders will be cashed out of their investment position and the company\u2019s shares will no longer be publicly traded.<\/p>\n<p>The investigation seeks to determine whether Checkpoint\u2019s shareholders will be receiving sufficient monetary consideration for their shares, and whether the company\u2019s officers and\/or directors breached their fiduciary duties or violated the securities laws in agreeing to the buyout price. Notably, at the time the proposed transaction was announced, several stock analysts were maintaining price targets for the company\u2019s shares well above the buyout price at between <strong><em>$7.00 &#8211; $9.00 per share<\/em><\/strong>.<\/p>\n<p>Checkpoint shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 \u2013 0750 for additional information about this investigation and their legal rights and options.<\/p>\n<p>\n        <strong><br \/>\n          <em>Alternatively, investors may submit their information to the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser):<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QVnJtehga4Iu1dbVzC3dOurqz4jkW4n4gyD8cXLaM_641VQCk_Zge7mCapi0NXxQsX3uY4b-goPG1fGJ0ChntqWvsXEAd6mMCennhQPA-0U_ftmLQ1X-4PKtUI7x2ZQW3FvJox5vEKZ7RlsZXBcSww==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <em>https:\/\/kaskelalaw.com\/case\/checkpoint\/<\/em><br \/>\n          <\/strong><br \/>\n        <\/a>\n      <\/p>\n<p>Kaskela Law LLC <em><u>exclusively<\/u><\/em> represents investors in securities fraud, corporate governance, and merger &amp; acquisition litigation on a contingent basis, which means that the firm\u2019s clients <em><u>never<\/u><\/em> pay any out-of-pocket costs for legal representation. For additional information about Kaskela Law LLC, including the firm\u2019s recent notable recoveries for investors, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MG9-5Fkj5hNbHYBw2k8TL7DKM21VvLbrhwL3pH8bdZcS9iZx5UkGgc97_jjss7evN-kB_SBPTlPMIU0n7N8cB4QYuVOEmOToNVSl2cbvIVA=\" rel=\"nofollow\" target=\"_blank\">www.kaskelalaw.com<\/a>.<\/p>\n<p>\n        <strong>CONTACT:<\/strong>\n      <\/p>\n<p>\n        <strong>KASKELA LAW LLC<\/strong><br \/>\n        <br \/>D. Seamus Kaskela, Esq.<br \/>(<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TZoMzB1-SOrkkikXEUaLPFtQ4fS4XMCNF4R98Np8jo03rg1Bu8u6xBpAmmQGgZHGPRyNvRo4ehDZRiPr4ndsCFUImHp33mRgpSQ7HqqB2OFIplSo-Vb0byCoTTWqPRI7\" rel=\"nofollow\" target=\"_blank\">skaskela@kaskelalaw.com<\/a>)<br \/>Adrienne Bell, Esq.<br \/>(<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UDXd2k5jm7EMbByqufJ2AeuFzr9MVxCutD8QYD_-NbrefayFLU2cWD3hPwk7At0nK9gH8omO29biJEIhjWy3Yh6Y6MSO_I3qykCZitCHJnI=\" rel=\"nofollow\" target=\"_blank\">abell@kaskelalaw.com<\/a>)<br \/>18 Campus Blvd., Suite 100<br \/>Newtown Square, PA 19073<br \/>(484) 229 \u2013 0750<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MG9-5Fkj5hNbHYBw2k8TL_7B4Vab7UPHJ4ot-FRmmgyCrp56Ov6EA-5jjeRImSI3F8j_SmVpjauuI8zI0id0efrYShAkwzPKQ9eLamTxpFw=\" rel=\"nofollow\" target=\"_blank\">www.kaskelalaw.com<\/a><\/p>\n<p>This notice may constitute attorney advertising in certain jurisdictions.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzY4OSM2ODAzNzY2IzIwOTk5MzU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTNiZDE5YzUtNDY5Ni00YTVlLTkxMjgtMzI4NDIwY2IzZjA1LTExMTE1MDYtMjAyNS0wMy0xMy1lbg==\/tiny\/Kaskela-Law.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PHILADELPHIA, March 13, 2025 (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating the fairness of the recently announced buyout of Checkpoint Therapeutics, Inc. (\u201cCheckpoint\u201d) (NASDAQ: CKPT) shareholders. Click here for additional information: https:\/\/kaskelalaw.com\/case\/checkpoint\/ On March 9, 2025, Checkpoint announced that it had agreed to be acquired by Sun Pharmaceutical Industries Ltd. at an upfront price of $4.10 per share in cash plus a non-transferable contingent value right (CVR) worth up to an additional $0.70 in cash upon the achievement of certain milestones. Following the closing of the proposed transaction, Checkpoint\u2019s shareholders will be cashed out of their investment position and the company\u2019s shares will no longer be publicly traded. The investigation seeks to determine whether Checkpoint\u2019s shareholders &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-825369","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, March 13, 2025 (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating the fairness of the recently announced buyout of Checkpoint Therapeutics, Inc. (\u201cCheckpoint\u201d) (NASDAQ: CKPT) shareholders. Click here for additional information: https:\/\/kaskelalaw.com\/case\/checkpoint\/ On March 9, 2025, Checkpoint announced that it had agreed to be acquired by Sun Pharmaceutical Industries Ltd. at an upfront price of $4.10 per share in cash plus a non-transferable contingent value right (CVR) worth up to an additional $0.70 in cash upon the achievement of certain milestones. Following the closing of the proposed transaction, Checkpoint\u2019s shareholders will be cashed out of their investment position and the company\u2019s shares will no longer be publicly traded. The investigation seeks to determine whether Checkpoint\u2019s shareholders &hellip; Continue reading &quot;SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-13T12:10:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzY4OSM2ODAzNzY2IzIwOTk5MzU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options\",\"datePublished\":\"2025-03-13T12:10:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/\"},\"wordCount\":370,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzY4OSM2ODAzNzY2IzIwOTk5MzU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/\",\"name\":\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzY4OSM2ODAzNzY2IzIwOTk5MzU=\",\"datePublished\":\"2025-03-13T12:10:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzY4OSM2ODAzNzY2IzIwOTk5MzU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzY4OSM2ODAzNzY2IzIwOTk5MzU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/","og_locale":"en_US","og_type":"article","og_title":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - Market Newsdesk","og_description":"PHILADELPHIA, March 13, 2025 (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating the fairness of the recently announced buyout of Checkpoint Therapeutics, Inc. (\u201cCheckpoint\u201d) (NASDAQ: CKPT) shareholders. Click here for additional information: https:\/\/kaskelalaw.com\/case\/checkpoint\/ On March 9, 2025, Checkpoint announced that it had agreed to be acquired by Sun Pharmaceutical Industries Ltd. at an upfront price of $4.10 per share in cash plus a non-transferable contingent value right (CVR) worth up to an additional $0.70 in cash upon the achievement of certain milestones. Following the closing of the proposed transaction, Checkpoint\u2019s shareholders will be cashed out of their investment position and the company\u2019s shares will no longer be publicly traded. The investigation seeks to determine whether Checkpoint\u2019s shareholders &hellip; Continue reading \"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-13T12:10:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzY4OSM2ODAzNzY2IzIwOTk5MzU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options","datePublished":"2025-03-13T12:10:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/"},"wordCount":370,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzY4OSM2ODAzNzY2IzIwOTk5MzU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/","name":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzY4OSM2ODAzNzY2IzIwOTk5MzU=","datePublished":"2025-03-13T12:10:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzY4OSM2ODAzNzY2IzIwOTk5MzU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzY4OSM2ODAzNzY2IzIwOTk5MzU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-into-fairness-of-checkpoint-therapeutics-inc-nasdaq-ckpt-buyout-offer-and-encourages-investors-to-contact-the-firm-to-d\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)\u00a0Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/825369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=825369"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/825369\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=825369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=825369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=825369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}